A new concept in the topical treatment of onychomycosis with cyanoacrylate, undecylenic acid, and hydroquinone.

Abstract	The authors report a pilot study of a new approach for the topical treatment of onychomycosis using physiologic principles of fungal growth and serial debridement. In total, 154 patients were studied for 1 year with mild, moderate, and severe nail disease. Negative mycologic cultures in these 3 groups were 100%, 65%, and 35%, respectively. All patients reported subjective improvement in the first 3 months.
Authors	Paul Rehder, Tim T Nguyen
Journal	Foot & ankle specialist (Foot Ankle Spec) Vol. 1 Issue 2 Pg. 93-6 (Apr 2008) ISSN: 1938-7636 [Electronic] United States
PMID	19825699 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Antifungal Agents Cyanoacrylates Hydroquinones Undecylenic Acids hydroquinone
Topics	Administration, Topical Adolescent Adult Aged Aged, 80 and over Antifungal Agents (administration & dosage) Child Cyanoacrylates (administration & dosage) Debridement Drug Therapy, Combination Female Foot Dermatoses (drug therapy) Humans Hydroquinones (administration & dosage) Male Middle Aged Onychomycosis (drug therapy) Treatment Outcome Undecylenic Acids (administration & dosage) Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!